MAP2K7 and hepatocellular carcinoma: ERK-Mediated Regulation of ncRNAs: In hepatocellular carcinoma (HCC), hyperactivation of the BRAF/MEK/ERK pathway drives tumor proliferation and drug resistance by modulating lncRNAs.